Gatifloxacin Ophthalmic

283 interactions 389 cited references
Also sold as: Zymar® Zymaxid Zymaxid®
About Gatifloxacin Ophthalmic

Gatifloxacin ophthalmic solution is used to treat bacterial conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids) in adults and children 1 year of age and older. Gatifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the… Read the full Gatifloxacin Ophthalmic drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dronedarone Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir
12 Contraindicated 254 Major 17 Moderate
All (283) Contraindicated (12) Major (254) Moderate (17)

Major

Gatifloxacin Ophthalmic Prochlorperazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Promazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Propafenone Rythmol Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Propiomazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Protriptyline An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Quetiapine Seroquel An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Quinidine Cardioquin® An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Quinine An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Quizartinib Vanflyta An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Ranolazine Aspruzyo An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Rasagiline Azilect Increased rasagiline exposure Details Gatifloxacin Ophthalmic Relugolix Orgovyx Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Repaglinide Prandin® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Revumenib Revuforj An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Ribociclib Kisqali An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Rilpivirine Edurant An increased risk of QT interval prolongation and torsade de pointes Details Gatifloxacin Ophthalmic Rosiglitazone Avandia® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Saxagliptin Onglyza Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Selpercatinib Retevmo Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Semaglutide Ozempic Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Sematilide An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Sertraline An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Sevoflurane Petrem Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Siponimod Mayzent An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Sitagliptin Brynovin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Sodium Phosphate OsmoPrep An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Sodium Phosphate, Dibasic An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Sodium Phosphate, Monobasic An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Solifenacin Vesicare An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Sorafenib Nexavar An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Sotalol Betapace An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Sulpiride An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Sunitinib Sutent An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Tacrolimus Astagraf An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Taletrectinib Ibtrozi Increased risk of QT interval prolongation and torsade de pointes Details Gatifloxacin Ophthalmic Tamoxifen Nolvadex® An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Tedisamil An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Telavancin Vibativ Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Telithromycin An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Tetrabenazine Xenazine An increased risk of QT interval prolongation and torsade de pointes Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.